Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa Extended Dosing in Anemia of CKD
NCT00440466Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2007
- Primary completion
- Mar 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Johnson & Johnson. Started Jul 2007; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00440466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440466.